Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycotoxins | 1 | 2024 | 12 | 0.880 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 67 | 0.810 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 218 | 0.710 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2011 | 203 | 0.550 |
Why?
|
| Lupus Nephritis | 2 | 2012 | 26 | 0.440 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2024 | 104 | 0.440 |
Why?
|
| Alzheimer Disease | 3 | 2026 | 1001 | 0.320 |
Why?
|
| Kidney | 1 | 2012 | 372 | 0.300 |
Why?
|
| Hepatitis | 1 | 2008 | 11 | 0.290 |
Why?
|
| Jaundice | 1 | 2008 | 7 | 0.280 |
Why?
|
| Spondylarthropathies | 1 | 2008 | 2 | 0.280 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2006 | 6 | 0.260 |
Why?
|
| Raynaud Disease | 1 | 2006 | 8 | 0.260 |
Why?
|
| Thrombosis | 1 | 2006 | 81 | 0.240 |
Why?
|
| Puerto Rico | 7 | 2026 | 1413 | 0.230 |
Why?
|
| tau Proteins | 1 | 2026 | 186 | 0.220 |
Why?
|
| Educational Status | 1 | 2026 | 339 | 0.210 |
Why?
|
| Peptide Fragments | 1 | 2026 | 307 | 0.200 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1285 | 0.200 |
Why?
|
| Apolipoprotein E4 | 2 | 2026 | 67 | 0.200 |
Why?
|
| Retrospective Studies | 3 | 2024 | 2544 | 0.180 |
Why?
|
| Female | 12 | 2026 | 24698 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2024 | 760 | 0.180 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 423 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2021 | 8 | 0.170 |
Why?
|
| Male | 11 | 2026 | 23409 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2021 | 430 | 0.170 |
Why?
|
| Hospitalization | 1 | 2024 | 485 | 0.160 |
Why?
|
| Middle Aged | 6 | 2026 | 12222 | 0.160 |
Why?
|
| Humans | 13 | 2026 | 43102 | 0.140 |
Why?
|
| Risk Factors | 2 | 2024 | 3994 | 0.140 |
Why?
|
| Aged | 4 | 2026 | 8214 | 0.140 |
Why?
|
| Adult | 9 | 2024 | 13872 | 0.140 |
Why?
|
| Drosophila | 1 | 2015 | 152 | 0.100 |
Why?
|
| Genome | 1 | 2015 | 149 | 0.100 |
Why?
|
| Virus Shedding | 1 | 2013 | 9 | 0.100 |
Why?
|
| Personnel, Hospital | 1 | 2013 | 11 | 0.100 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 188 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 307 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2013 | 35 | 0.100 |
Why?
|
| Young Adult | 5 | 2024 | 5080 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2013 | 27 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 36 | 0.100 |
Why?
|
| Genomics | 1 | 2015 | 293 | 0.090 |
Why?
|
| Biopsy | 1 | 2012 | 177 | 0.090 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 59 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2026 | 1759 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2011 | 172 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 58 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 94 | 0.070 |
Why?
|
| Disease Progression | 1 | 2011 | 667 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 236 | 0.070 |
Why?
|
| Adolescent | 3 | 2013 | 6081 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2008 | 587 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2026 | 2853 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2024 | 71 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 70 | 0.050 |
Why?
|
| Wound Healing | 1 | 2024 | 88 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 134 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 167 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 1612 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 3156 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2011 | 147 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 386 | 0.040 |
Why?
|
| Logistic Models | 2 | 2013 | 1009 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 206 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2018 | 121 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2010 | 1604 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 17 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 36 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2015 | 19 | 0.030 |
Why?
|
| Codon | 1 | 2015 | 39 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 79 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 55 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 92 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2015 | 75 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 286 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 193 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 22 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 54 | 0.020 |
Why?
|
| Infection Control | 1 | 2013 | 18 | 0.020 |
Why?
|
| Tennessee | 1 | 2013 | 93 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 327 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2013 | 92 | 0.020 |
Why?
|
| Complement C4 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Proteinuria | 1 | 2011 | 56 | 0.020 |
Why?
|
| Vaccination | 1 | 2013 | 355 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 440 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 518 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2010 | 37 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2010 | 91 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 1600 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 861 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 737 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1154 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 16992 | 0.010 |
Why?
|